Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease

BACKGROUND: Tumor necrosis factor-alpha inhibitors, including infliximab and adalimumab, are effective medical treatments for perianal fistulising Crohn’s disease (CD), but not all patients achieve fistula healing. AIM: To determine the correlation between perianal fistula healing and closure with i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Bonita, Venkatesh, Kavya, Williams, Astrid-Jane, Ng, Watson, Corte, Crispin, Gholamrezaei, Ali, Ghaly, Simon, Xuan, Wei, Paramsothy, Sudarshan, Connor, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254145/
https://www.ncbi.nlm.nih.gov/pubmed/35949350
http://dx.doi.org/10.3748/wjg.v28.i23.2597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254145/
https://www.ncbi.nlm.nih.gov/pubmed/35949350
http://dx.doi.org/10.3748/wjg.v28.i23.2597

Ejemplares similares